In our study, L-NAME was used to inhibit the expression of eNOS and to demonstrate the important role of eNOS in the mechanism of NASH-related fibrosis both in vivo and in vitro. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatohepatitis.